Newsletters
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
EPA (part 2, streptomycin!) / $104m ARPA-H AMR project
Dear All (OK, so now it’s 5 newsletters in as many days … exciting times … can’t keep up!), Two
Read More >
EPA Concept Note (Part 1): AMR risks of antibacterial or antifungal pesticides
There is a follow-up newsletter that expands on the EPA concept note. Dear All, What a week … and I
Read More >
BARDA Medical Countermeasures BAA: Substantial updates
Dear All (and yes, back-to-back newsletters … lots of action this week!): BARDA have today released a new version of their
Read More >
Appropriate duration of antimicrobial dosing in food animal care
Dear All, I’ve watched with interest the way that FDA’s CVM (Center for Veterinary Medicine) has been working steadily with
Read More >
Manufacturing underpins both access and stewardship: Cefiderocol as a case study
Dear All, Prompted by an excellent talk by GARDP’s Jennifer Cohn at last week’s ASM-ESCMID Developer’s conference, today I’d like
Read More >
How the sausage is made: A day of advocacy for PASTEUR
Dear All, Along with more than 50 others, I spent Tuesday 12 Sep 2023 on Capitol Hill visiting offices of
Read More >
Fireside Chat with Lynn Silver! Deep Dive on Drug Discovery: Chemical Vs. Drugs (Part 5)
Note: For those of you with an interest in developing bacterial vaccines, the results of Pfizer’s failed STRIVE S. aureus
Read More >
Canada says, “Let’s pull together!” in a major new report
Dear All (and with thanks to Kevin for co-authoring): Yesterday saw the release of a major new report on Pull
Read More >
€100m HERA Invest fund; Sign to support PASTEUR; Superb AMR movie!
Dear All, Expanding the available Push funding, the EU’s HERA (Health Emergency Preparedness and Response Authority) has created HERA Invest
Read More >
ENABLE-2: Rolling call for hit-to-lead projects is now open
Dear All, Summer is coming to a close … hard to believe it’s almost September! To get you going for
Read More >
MHLW plan to pilot Pull incentives in Japan: Further details
Dear All, As a follow up the 19 Aug 2023 newsletter on MHLW’s work on Pull incentives (and with thanks
Read More >
Canada joins UK and Germany to support CARB-X; Japan’s MHLW investigates Pull!
Dear All, Some great news today! We have visible evidence of global government action in support of the addressing our antibiotic
Read More >
Antibiograms: Polishing a cloudy crystal ball
Dear All, A recent paper by Hasegawa et al. and a multi-paper supplement, both in Clinical Infectious Diseases, combine to
Read More >
What is that pill? ASM Policy paper! A movie trailer!
Dear All, Today we have a collection of things all related to the global efforts to fight AMR. Two papers,
Read More >
WHO seeks Consultant to lead Campaign to Prevent Non-Prescription Antibiotic Use!
Dear All, The WHO is looking for a consultant to develop a campaign to prevent non-prescription antibiotic sales! This 4-month
Read More >
UK to expand NHS Subscription Pilot! Consultation Period launches
Dear All (and with thanks to Kevin for co-authoring), The UK NHS England Pilot is known to us all as the first
Read More >
EU Council Recommendation adopted! But what does it mean?
Dear All, During their recent turn to hold the EU presidency (1 Jan to 30 Jun 2023), the Swedes have
Read More >
NCI’s natural product library: A 326,656 compound update!
Dear All, I wrote in 2018 about National Cancer Institute’s Natural Products Branch (NPB) and its program for Natural Product Discovery
Read More >
PASTEUR action; Wellcome convenes Global R&D discussion!
Dear All, Two items for your attention today: an immediate action for you to take to support PASTEUR plus a launch
Read More >
AI-based drug discovery: Chemical vs. drugs (Part 4)
Dear All, We had fun in Feb 2020 discussing whether an antibacterial compound discovered using machine learning was a drug
Read More >
